BARBIERI, Maria Antonietta
 Distribuzione geografica
Continente #
NA - Nord America 3.851
EU - Europa 2.355
AS - Asia 1.345
SA - Sud America 367
Continente sconosciuto - Info sul continente non disponibili 134
AF - Africa 61
OC - Oceania 6
Totale 8.119
Nazione #
US - Stati Uniti d'America 3.705
RU - Federazione Russa 1.347
SG - Singapore 560
IT - Italia 325
CN - Cina 308
BR - Brasile 294
HK - Hong Kong 154
IE - Irlanda 149
SE - Svezia 127
VN - Vietnam 78
DE - Germania 77
CA - Canada 70
IN - India 68
PL - Polonia 52
FR - Francia 50
GB - Regno Unito 48
BD - Bangladesh 39
EE - Estonia 34
FI - Finlandia 34
IQ - Iraq 22
MX - Messico 21
NL - Olanda 21
AR - Argentina 18
ZA - Sudafrica 18
TR - Turchia 16
UA - Ucraina 16
JP - Giappone 15
CO - Colombia 14
ES - Italia 14
ID - Indonesia 14
BE - Belgio 12
EC - Ecuador 12
MA - Marocco 11
AT - Austria 10
CR - Costa Rica 10
CL - Cile 9
VE - Venezuela 9
HN - Honduras 8
CI - Costa d'Avorio 7
IL - Israele 7
PK - Pakistan 7
JM - Giamaica 6
SC - Seychelles 6
CZ - Repubblica Ceca 5
LT - Lituania 5
SV - El Salvador 5
TH - Thailandia 5
UY - Uruguay 5
AE - Emirati Arabi Uniti 4
BG - Bulgaria 4
CW - ???statistics.table.value.countryCode.CW??? 4
EG - Egitto 4
GP - Guadalupe 4
GT - Guatemala 4
LB - Libano 4
MY - Malesia 4
OM - Oman 4
PA - Panama 4
PH - Filippine 4
PY - Paraguay 4
SA - Arabia Saudita 4
TW - Taiwan 4
UZ - Uzbekistan 4
AZ - Azerbaigian 3
CH - Svizzera 3
DZ - Algeria 3
JO - Giordania 3
KZ - Kazakistan 3
NO - Norvegia 3
NP - Nepal 3
RO - Romania 3
RS - Serbia 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
AL - Albania 2
AU - Australia 2
BO - Bolivia 2
BS - Bahamas 2
GE - Georgia 2
GR - Grecia 2
KE - Kenya 2
LV - Lettonia 2
NI - Nicaragua 2
PR - Porto Rico 2
PT - Portogallo 2
SN - Senegal 2
BN - Brunei Darussalam 1
BY - Bielorussia 1
BZ - Belize 1
CD - Congo 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
HU - Ungheria 1
IS - Islanda 1
KG - Kirghizistan 1
KN - Saint Kitts e Nevis 1
LK - Sri Lanka 1
LY - Libia 1
MN - Mongolia 1
MQ - Martinica 1
Totale 7.978
Città #
Ashburn 513
Moscow 359
Singapore 348
Dallas 281
San Jose 169
Chandler 161
Hong Kong 154
Dublin 148
Beijing 96
Los Angeles 93
Council Bluffs 70
Nyköping 65
New York 59
Messina 56
The Dalles 56
Santa Clara 48
Warsaw 48
Munich 39
Rome 35
Denver 33
Orem 30
São Paulo 28
Atlanta 27
San Francisco 25
Brooklyn 24
Ho Chi Minh City 23
North Bergen 23
Hyderabad 22
Boston 21
Frankfurt am Main 21
Lauterbourg 21
Turku 21
Milan 20
Princeton 20
Buffalo 19
Toronto 19
Medford 18
Seattle 18
Tianjin 18
Montreal 17
Hanoi 15
Redondo Beach 15
Columbus 14
Phoenix 14
Amsterdam 13
Catania 13
Dearborn 13
Jacksonville 13
Brussels 12
Des Moines 12
Guangzhou 12
Baghdad 11
Belo Horizonte 11
Chennai 11
Chicago 11
London 11
Naples 11
Stockholm 11
Tokyo 11
Mexico City 10
Boardman 9
Houston 9
Paternò 9
Rio de Janeiro 9
Shanghai 9
Helsinki 8
Jakarta 8
Johannesburg 8
Mumbai 8
Vienna 8
Wilmington 8
Abidjan 7
Bari 7
Pune 7
Salvador 7
Bremen 6
Brescia 6
Changsha 6
Lamezia Terme 6
Memphis 6
Miami 6
Nuremberg 6
San José 6
Santiago 6
Bexley 5
Calgary 5
Charlotte 5
João Pessoa 5
Lawrenceville 5
Manchester 5
Medellín 5
Montevideo 5
New Delhi 5
Palermo 5
San Salvador 5
Shenzhen 5
Vancouver 5
Bologna 4
Brasília 4
Brno 4
Totale 3.762
Nome #
Clinically Relevant Drug Interactions Between Statins and Antidepressants 900
Clinically Relevant Interactions between Atypical Antipsychotics and Anti-Infective Agents 483
Safety and Tolerability of Antipsychotic Drugs in Pediatric Patients: Data From a 1-Year Naturalistic Study 318
Neuropsychiatric Adverse Events with Monoclonal Antibodies Approved for Multiple Myeloma: An Analysis from the FDA Adverse Event Reporting System 269
Anti-obesity drug therapy in clinical practice: Evidence of a poor prescriptive attitude 245
Safety profile of tyrosine kinase inhibitors used in non-small-cell lung cancer: An analysis from the Italian pharmacovigilance database 242
Characterization and preventability of adverse drug events as cause of emergency department visits: a prospective 1-year observational study 237
A comprehensive review of swallowing difficulties and dysphagia associated with antipsychotics in adults. 236
Adverse Drug Reactions with Drugs Used in Multiple Sclerosis: An Analysis from the Italian Pharmacovigilance Database 220
Clinically relevant drug interactions between newer antidepressants and oral anticoagulants 213
Anticancer and anti-inflammatory properties of ganoderma lucidum extract effects on melanoma and triple-negative breast cancer treatment 212
Ototoxic adverse drug reactions: A disproportionality analysis using the Italian spontaneous reporting database 199
Effectiveness and safety profile of mepolizumab in chronic rhinosinusitis with nasal polyps: Real life data in a tertiary care 197
Chronic Kidney Disease Management in General Practice: A Focus on Inappropriate Drugs Prescriptions 196
Adverse drug reactions with oral anticoagulants: data from sicilian spontaneous reporting system database 192
Effectiveness and Safety Profiles of Biological Therapies in Inflammatory Bowel Disease: Real Life Data from an Active Pharmacovigilance Project 189
Adverse Drug Reactions with HER2-Positive Breast Cancer Treatment: An Analysis from the Italian Pharmacovigilance Database 174
Pediatric adverse reactions to antiseizure medications – An analysis of data from the Italian spontaneous reporting system (2001–2019) 172
Safety and tolerability of antipsychotic drugs in pediatric patients: data from an ongoing active pharmacovigilance study in Sicily 171
Effectiveness and safety profile of dupilumab in chronic Rhinosinusitis with nasal polyps: real-life data in tertiary care 169
Kidney Disease Management in the Hospital Setting: A Focus on Inappropriate Drug Prescriptions in Older Patients 165
Management of High Cardiovascular Risk in Diabetic Patients: Focus on Low Density Lipoprotein Cholesterol and Appropriate Drug Use in General Practice 161
Safety Profile of Biologics Used in Rheumatology: An Italian Prospective Pharmacovigilance Study 157
Cardiovascular Adverse Drug Reactions of Anti-Calcitonin Gene-Related Peptide Monoclonal Antibodies for Migraine Prevention: An Analysis from the European Spontaneous Adverse Event Reporting System 142
Beta-Blocker Use in Older Hospitalized Patients Affected by Heart Failure and Chronic Obstructive Pulmonary Disease: An Italian Survey From the REPOSI Register 140
Comparison Study of the Safety Profile of Olaparib Versus Niraparib: Analysis of Real-World Data from EudraVigilance 130
Management of patients with inflammatory bowel diseases: evaluating effectiveness, safety, and drug repurposing strategies 126
Dupilumab in chronic rhinosinusitis with nasal polyps: Real life data in a multicentric Sicilian experience 121
Neuropsychiatric Adverse Drug Reactions with Tyrosine Kinase Inhibitors in Gastrointestinal Stromal Tumors: An Analysis from the European Spontaneous Adverse Event Reporting System 116
Neuropsychiatric adverse drug reactions with oral tyrosine kinase inhibitors in metastatic colorectal cancer: an analysis from the FDA Adverse Event Reporting System 112
Comparing major and mild cognitive impairment risks in older type-2 diabetic patients: a Danish register-based study on dipeptidyl peptidase-4 inhibitors vs. glucagon-like peptide-1 analogues 110
Cardiovascular Safety Profile of BRAF and MEK Inhibitors in Melanoma: FAERS Data Through a Retrospective Disproportionality Analysis (2014–2023) 100
Impact of the COVID-19 Pandemic on Chronic Neurological Disorders: Focus on Patients with Dementia 93
The intertwining of healthcare-associated infections and COVID-19 in Italian intensive care units: an analysis of the SPIN-UTI project from 2006 to 2021 91
Artificial intelligence for the optimal management of community-acquired pneumonia 87
Cenobamate: A Review of its Pharmacological Properties, Clinical Efficacy and Tolerability Profile in the Treatment of Epilepsy 84
Timing Matters: A Machine Learning Method for the Prioritization of Drug–Drug Interactions Through Signal Detection in the FDA Adverse Event Reporting System and Their Relationship with Time of Co-exposure 84
Renal Disorders with Oral Tyrosine Kinase Inhibitors in Metastatic Colorectal Cancer: An Analysis from the FDA Adverse Event Reporting System Database 84
Unveiling cardiovascular and respiratory toxicities with monoclonal antibodies in multiple myeloma: disproportionality analysis from the FDA Adverse Event Reporting System 83
Optimization of Therapy in Patients with Epilepsy and Psychiatric Comorbidities: Key Points 80
Tolerability profile of paliperidone palmitate formulations: A pharmacovigilance analysis of the EUDRAVigilance database 72
Drug Repurposing in Crohn’s Disease Using Danish Real-World Data 68
Safety of Dual Orexin Receptor Antagonist Daridorexant: A Disproportionality Analysis of Publicly Available FAERS Data 65
Network Analysis and Machine Learning for Signal Detection and Prioritization Using Electronic Healthcare Records and Administrative Databases: A Proof of Concept in Drug-Induced Acute Myocardial Infarction 59
Drug Safety and Relevant Issues in the Real-World 52
Exploring the impact of co-exposure timing on drug-drug interactions in signal detection through spontaneous reporting system databases: a scoping review 49
Proprotein convertase subtilisin/kexin type 9: a promising marker of cardiovascular risk in post-menopausal diabetic women in primary prevention 41
A newly developed method for assessing co-exposure to free dose combinations: a proof-of-concept study using antihypertensive medications in Danish registers 41
Mepolizumab in chronic rhinosinusitis with nasal polyps: Real life data in a multicentric Sicilian experience 40
Factors Associated with Parental Vaccine Hesitancy in Childhood Immunization: Insights from a Cross-Sectional Survey in Southern Italy 30
Artificial intelligence in pharmacovigilance signal management: a review of tools, implementations, research, and regulatory landscape 26
Long non-coding RNA NEAT1 targeting impairs the DNA repair machinery and triggers anti-tumor activity in multiple myeloma 24
null 22
Exploring drug interactions between newer antidepressants and medications used to treat neurological disorders 16
An update on the pharmacokinetic and pharmacodynamic interactions between antidepressants and antiseizure medications 14
Totale 8.119
Categoria #
all - tutte 22.769
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.769


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022150 0 0 0 2 10 9 8 7 0 47 5 62
2022/2023476 33 56 20 51 26 43 7 49 174 1 14 2
2023/2024185 12 16 23 13 12 33 19 8 4 25 6 14
2024/20251.143 21 17 28 72 37 54 68 188 228 121 152 157
2025/20263.648 223 177 303 261 286 612 434 486 455 231 79 101
2026/20272.341 256 898 684 503 0 0 0 0 0 0 0 0
Totale 8.119